Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2022-08-24 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2022 半年度报告摘要' which translates to '2022 Half-Year Report Summary'. It contains detailed financial data for the half-year period, including total assets, net profit, revenue, earnings per share, and shareholder information. The document explicitly states it is a summary of the half-year report and references the full half-year report for more details. The length is 3249 characters, which is relatively short but contains substantive financial data and analysis for the half-year period. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial statements and substantive financial data. It is not merely an announcement or a certification, but includes financial figures and management discussion. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2022
2022-08-24 Chinese
和元生物技术（上海）股份有限公司独立董事关于第二届董事会第二十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from independent directors regarding several matters discussed at the company's board meeting, including the review of a mid-year report on the use of raised funds, opinions on the replacement of self-raised funds with raised funds, and the nomination of non-independent and independent directors for the board. The document references compliance with laws and regulations and confirms the legitimacy of board nominations and fund usage. It does not contain actual financial statements or detailed financial data but rather expresses independent directors' opinions on specific governance and financial management issues. The document is not a full annual or interim report, nor is it a simple announcement or certification. It is related to board/management information, specifically about board nominations and governance matters. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 1932 characters, which is relatively short and consistent with a board opinion statement rather than a full report.
2022-08-24 Chinese
关于参与设立创业投资基金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by a company regarding its participation in establishing a venture capital fund. It details the investment amount, partners, fund structure, decision-making process, and risk disclosures. There are no financial statements, quarterly or annual results, or audit information. The document is a formal disclosure about a capital investment activity, specifically about financing and investment in a fund. It is not a report, earnings release, or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 4719 characters, which is sufficient for a detailed announcement but not a full financial report.
2022-07-12 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the completion of business registration changes and the issuance of a new business license. It references prior announcements and shareholder meeting resolutions related to changes in registered capital, company type, and articles of association. The document is short (975 characters) and serves as a formal notification of completed administrative changes rather than a detailed financial report or management discussion. It does not contain financial statements, audit information, or detailed governance reports. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-07-06 Chinese
关于董事会、监事会延期换届的提示性公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from a company regarding the postponement of the board of directors and supervisory board re-election. It discusses the extension of the current board and management terms to ensure continuity and stability. There is no financial data, no mention of annual or quarterly reports, no voting results, and no mention of any other report types. The content is about management/board changes and governance continuity. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2022-07-06 Chinese
关于子公司完成工商变更登记并换发营业执照的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about its subsidiary completing a business registration change and obtaining a new business license. It details the increase in registered capital of the subsidiary and references a previous announcement about the use of raised funds. The document is short (1062 characters) and does not contain financial statements or detailed financial data. It is an official announcement about corporate changes related to capital investment and registration, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-07-06 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.